(CPTS, CRWE, PRPH, PRGO) Stock in Focus by CRWEWallStreet.com

Conceptus, Inc. (Nasdaq:CPTS) announced that the U.S. Food and Drug Administration (FDA) approved labeling changes pertaining to the use of bipolar radio frequency (RF) NovaSure(R) Impedance Controlled Endometrial Ablation System(1) following the placement of Essure inserts and a successful Essure Confirmation Test. The expanded label change followed the Company and the FDA reaching an agreement on the post-approval study (PAS) protocol. Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and Europe. It primarily provides Essure, a permanent birth control system that delivers a soft and flexible insert into a woman’s fallopian tubes. **************************************** Crown Equity Holdings Inc. (CRWE) Crown Equity Holdings Inc. (CRWE.OB) www.crownequityholdings.com announced that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with MVOX AG. MVOX AG, located in Germany, will work with Crown Tele Services Inc. www.crownteleservices.com as a technological partner in offering wireless broadband solutions (wireless carrier class infrastructure in high speed data and WiMAX). Commenting on the Letter of Intent, “The keystone of our business has always been our commitment to meeting our customers’ network needs and we will continue to grow with this principle,” said Kenneth Bosket, Crown Tele Services Inc., President and CEO. Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions and is a subsidiary of Crown Equity Holdings Inc. For more information visit www.crownteleservices.com. Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. VoIP service provides standard features like voicemail, caller ID, and call waiting, as well as advanced features like video conferencing, call tracking, and online system management. MVOX AG offers wireless broadband internet access services with over 15 years of experience as a system integrator, as well as being the most successful WiMAX operator in Germany. The company is based in Garching a.d. Alz, Germany. For more information about Crown Equity Holdings Inc., please visit: www.crownequityholdings.com **************************************** ProPhase Labs (NASDAQ:PRPH) announced that financial results for the fourth quarter and the year ended December 31, 2011, will be released before the market opens on Tuesday, March 6, 2012. ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) cold remedy and consumer products, natural base health products, and other supplements and cosmeceuticals in the United States. **************************************** Perrigo Company (Nasdaq:PRGO) announced that it has initiated market launch and made its first shipments of minoxidil 5% foam to its retail and wholesale customers. Marketed under store or own label brands, minoxidil 5% foam is comparable to Rogaine® 5% Foam Hair Regrowth Treatment. Rogaine® 5% Foam is a treatment for the regrowth of hair on the top of the scalp and its estimated annual sales are approximately $60 million. Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide. Sign Up For Free Stock Alerts At http://crwewallstreet.com/signup ****************************************************************************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.